INTC
37
-4
MMC
60
-2
HRB
70
-3
FLS
46
-7
MRK
53
3
NFLX
55
-3
COST
51
-3
TRV
64
-3
NSC
62
2
ABT
57
-9
VRSK
35
-3
VFC
57
4
EBAY
50
-3
VRSN
50
-5
SRE
54
-5
BAX
35
-3
AMAT
49
-3
CME
56
-3
ES
55
-5
LMT
40
-5
INTC
37
-4
MMC
60
-2
HRB
70
-3
FLS
46
-7
MRK
53
3
NFLX
55
-3
COST
51
-3
TRV
64
-3
NSC
62
2
ABT
57
-9
VRSK
35
-3
VFC
57
4
EBAY
50
-3
VRSN
50
-5
SRE
54
-5
BAX
35
-3
AMAT
49
-3
CME
56
-3
ES
55
-5
LMT
40
-5
Financhill
Back

Predictive Oncology Vs. Perspective Therapeutics Industry Stock Comparison

Sell
37

POAI
Predictive Oncology

Last Price:
0.90
Seasonality Move:
-7.5%
Sell
31

CATX
Perspective Therapeutics

Last Price:
13.38
Seasonality Move:
-10.19%
Sell
37
Predictive Oncology (POAI) is a Sell

Is Predictive Oncology a Buy, Sell or Hold?

  • The current Predictive Oncology [POAI] share price is $0.88. The Score for POAI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • POAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.35. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

POAI Stock Price Chart

What is Predictive Oncology's stock price today?

  • The Predictive Oncology share price today is $0.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and POAI is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

POAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.16 Sell
Chaikin Money Flow: -43529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.89 - 0.95) Sell
Bollinger Bands (100): (0.91 - 1.53) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 41.91 Sell
Chaikin Money Flow: -533654 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.94 - 15.76) Sell
Bollinger Bands (100): (11.54 - 15.98) Sell

POAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.92 Sell
20-day SMA: 0.92 Sell
50-day SMA: 1.02 Sell
200-day SMA: 1.99 Sell
8-day EMA: 0.91 Sell
20-day EMA: 0.93 Sell
50-day EMA: 1.03 Sell
200-day EMA: 1.98 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.73 Sell
20-day SMA: 15.07 Sell
50-day SMA: 13.7 Sell
200-day SMA: 11.22 Buy
8-day EMA: 14.29 Sell
20-day EMA: 14.54 Sell
50-day EMA: 13.97 Sell
200-day EMA: 11.48 Buy

Predictive Oncology Earnings Growth & POAI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Predictive Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):